MedTrace Logo

A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women

NCT00860964 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2009-03-17

No results posted yet for this study

Summary

The purpose of this trial is to study the efficacy and safety of low dose of estradiol valerate in the prevention and treatment of postmenopausal osteoporosis.

Conditions

Interventions

DRUG

Placebo

Placebo, calcium 900mg/d, VitD200iu/d and exercise

DRUG

estradiol valerate

estradiol valerate 1mg/d,medroxyprogesterone 6mg/d for 10 days,calcium 900mg/d, VitD200iu/d and exercise

Sponsors & Collaborators

  • Peking Union Medical College

    lead OTHER

Principal Investigators

  • Shou Q Lin, PhD · Gynecological endocrinology & women's health centre of Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1998-02-28
Primary Completion
2003-02-28
Completion
2006-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00860964 on ClinicalTrials.gov